Pharmaceuticals & Therapeutics

A new FDA-cleared system from Chest Wall Innovations offers both PEEK and titanium implants, promising surgeons unprecedented versatility in treating rib fractures.

With a fourfold revenue jump, China's Yangtze River Pharmaceutical Group isn't just selling drugs; it's exporting a new model of global trust and quality.

New MD Andreas Goppelt brings a bold M&A and digital transformation agenda to OrphaCare, aiming to reshape rare disease patient care globally.

While the global glove industry faced oversupply and price wars, INTCO Medical achieved a four-year revenue high through strategic innovation and expansion.

Genomics' big data and Greywolf's novel drugs unite to develop first-in-class treatments for autoimmune diseases, promising a new era of precision medicine.

A landmark study reveals a hidden genetic cause for a common kidney disease in adults, urging for expanded genetic screening and paving the way for new therapies.

With a solid 2025 behind them, investors are watching Bioventus's Q1 results for signs of continued momentum in innovation and profitability.

Cordis launches the first sirolimus-eluting balloon for peripheral artery disease in Japan, backed by strong 3-year clinical data showing durable results.

With financials improving but competition rising, medical device maker Pulmonx faces a critical audience at the BofA healthcare conference in May.

The pharma giant reports a net loss after a major write-down, but management points to a strong consumer division and a CDMO rebound as signs of recovery.

Promising physician access in seconds, CirrusMD's new model, backed by Quantum Health, tackles the care crisis. But can it overcome virtual care's hurdles?

Kiniksa raises its 2026 ARCALYST forecast after a blowout quarter, using its financial strength to advance a pipeline aimed at redefining pericarditis care.

BRC Therapeutics gets the FDA green light for BRC-002, a novel cannabinoid drug for CRPS, a severe pain condition with no approved US treatments.

Pharma manufacturer Mikart cuts the ribbon on a new Atlanta HQ while boosting bottling capacity by 50%, tackling industry demand and fueling local growth.

Formerly LA Cancer Network, Oncura Health's new Los Alamitos clinic brings advanced, physician-led oncology services to a competitive Orange County market.

A new therapy programs immune cells inside the body to fight disease. Sail Biomedicines is pioneering this approach to offer a potential cure for autoimmunity.

A Leominster senior community earned top national honors from U.S. News & World Report. Discover what this data-driven award reveals about quality of care.

A Shelton community earns top national honors from U.S. News & World Report, a distinction driven entirely by outstanding resident and family feedback.

New Phase 2a data reveals Oruka Therapeutics' ORKA-001 achieved complete skin clearance in nearly two-thirds of patients, positioning it as a potential game-changer.

Alliance Cancer Specialists and IDEOlogy Health unite to bring the latest cancer research directly to community care teams, enhancing patient outcomes.